BUZZ-U.S. STOCKS ON THE MOVE-Celldex, Iconix, Pier 1, gold miners
(For faster updates on individual market-movers, Eikon users please use search string "STXBZ US"; for the Day Ahead newsletter, link.reuters.com/mex49s; for the Morning News Call newsletter, link.reuters.com/nex49s) Wall Street was set to open lower on Monday after the S&P 500 and the Dow recorded their first four-day winning streak in about five months last week. Dow Jones industrial average futures were down 0.30 percent at 16,916, S&P 500 futures were down 0.41 percent at 1,986.75 and Nasdaq 100 futures were down 0.44 percent at 4,303.5.
** CELLDEX THERAPEUTICS INC, Friday close $8.19, -52.38 pct premarket
The drug developer said it would discontinue a late-stage study of its brain cancer vaccine after an independent interim analysis suggested the therapy might not show a statistically significant difference in survival rates compared with chemotherapy.
** VANGUARD NATURAL RESOURCES LLC, Friday close $2.61, -13.79 pct premarket
The oil and natural gas producer suspended distributions on its common and preferred units on Friday. FBR Capital Markets downgraded the stock to "market perform" from "outperform", saying the suspension was likely influenced by the company's upcoming borrowing base redetermination.
** BIOCRYST PHARMACEUTICALS INC, Friday close $2.58, +15.50 pct premarket Continued...